Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis

Lee, Esak, Fertig, Elana J., Jin, Kideok, Sukumar, Saraswati, Pandey, Niranjan B., Popel, Aleksander S.·2014·Nature Communications
DOI 10.1038/ncomms5715

Cited by (199)

Items 101–199 of 199

  1. Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
    Leticia Oliveira‐Ferrer, Karin Milde‐Langosch, Kathrin Eylmann, Maila Roßberg, Volkmar Müller, Barbara Schmalfeldt, Isabell Witzel, Jasmin Wellbrock, Walter Fiedler · 2020 · International Journal of Molecular Sciences
  2. Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment
    Cristina Viúdez-Pareja, Ewa A. Kreft, Melissa García‐Caballero · 2023 · Frontiers in Immunology
  3. CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis
    Yanchun Huang, Lijuan Wu, Yong Sun, Jiwen Li, Nan Mao, Yeqing Angela Yang, Minglei Zhao, Sichong Ren · 2023 · Heliyon
  4. Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond
    Andrea Nicolini, Paola Ferrari · 2024 · Cancers
  5. Multiscale Modeling of Cancer
    Kerri‐Ann Norton, Meghan McCabe Pryor, Aleksander S. Popel · 2015 · bioRxiv (Cold Spring Harbor Laboratory)
  6. TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis
    Qian-zhi Chen, Yan Chen, Xia Li, Hao Liu, Xuling Sun · 2022 · Current Medical Science
  7. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer
    Li Pan, Xiang Chen, Shengling Fu, Wenying Yu, Chenglong Li, Tiffany L. Wang, Hui‐Wen Lo, Jiayuh Lin · 2020 · Breast Cancer Research and Treatment
  8. Immune Checkpoint Inhibitors and Other Immune Therapies in Breast Cancer: A New Paradigm for Prolonged Adjuvant Immunotherapy
    Andrea Nicolini, Paola Ferrari, Angelo Carpi · 2022 · Biomedicines
  9. Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung
    Zhengzheng Zhang, Zhiyan Yao, Zimeng Zhang, Ling Cui, Ling Zhang, Gang Qiu, Xiaotian Song, Shuxia Song · 2023 · Cancer Cell International
  10. Forces at play: exploring factors affecting the cancer metastasis
    Farooq Riaz, Jing Zhang, Fan Pan · 2024 · Frontiers in Immunology
  11. Differential osteopontin expression in human osteoblasts derived from iliac crest and alveolar bone and its role in early stages of angiogenesis
    Martin Wein, Diana Hülter-Hassler, Katja Nelson, Tobias Fretwurst, Susanne Nahles, Guenter Finkenzeller, Brigitte Altmann, Thorsten Steinberg · 2018 · Journal of Bone and Mineral Metabolism
  12. Challenges and opportunities for cell line secretomes in cancer proteomics
    Olga Méndez, Josep Villanueva · 2014 · PROTEOMICS - CLINICAL APPLICATIONS
  13. The role of ELK3 to regulate peritumoral lymphangiogenesis and VEGF-C production in triple negative breast cancer cells
    Nuri Oh, Ji-In Park, Jihoon Park, Kwangsoo Kim, Dong Ryul Lee, Kyung‐Soon Park · 2017 · Biochemical and Biophysical Research Communications
  14. Perfluorocarbon Nanoemulsions for Combined Pulmonary siRNA Treatment of Lung Metastatic Osteosarcoma
    Zhaoting Li, Yuexin Shen, Yixin Wang, Lianghan Zhu, Chenfei Zhu, Chenggen Qian, Minjie Sun, David Oupický · 2019 · Advanced Therapeutics
  15. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment
    Daniela Rudgeri Derossi, Marla Karine Amarante, Roberta Losi Guembarovski, Carlos Eduardo Coral de Oliveira, Karen M. Suzuki, Maria Angélica Ehara Watanabe, Ilce Mara de Syllos Cólus · 2019 · Molecular Biology Reports
  16. Microphysiological Systems for Cancer Immunotherapy Research and Development
    Yansong Peng, Esak Lee · 2023 · Advanced Biology
  17. Hypoxia and the Tumor Secretome
    Ying Liu, Gabrielle E. Ciotti, T.S. Karin Eisinger‐Mathason · 2019 · Advances in experimental medicine and biology
  18. Transforming Cancer Therapy: Unlocking the Potential of Targeting Vascular and Stromal Cells in the Tumor Microenvironment
    Lu Liu, Yuheng Zhang, Hanyu Liu, Jian Yang, Qi Tian, Nareekarn Chueakula, Saravana Kumar Ramasamy, Navin Kumar Verma, Christine Cheung, Anjali P. Kusumbe · 2025 · Cancer Research
  19. Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer
    Yung‐Chi Huang, Chao‐Yuan Chang, Yu‐Yuan Wu, Kuan‐Li Wu, Ying‐Ming Tsai, Hsiao-Chen Lee, Eing‐Mei Tsai, Ya‐Ling Hsu · 2022 · Cancers
  20. CD24hiCD27+ Bregs within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer
    Huanhuan Huang, Yao Yao, Lesang Shen, Jingxin Jiang, Ting Zhang, Jia Xiong, Jiaxin Li, Shanshan Sun, Siwei Zheng, Fang Jia et al. · 2023 · Clinical Cancer Research
  21. Podoplanin is Responsible for the Distinct Blood and Lymphatic Capillaries
    Donghyun Paul Jeong, Eva Hall, Erin Neu, Donny Hanjaya‐Putra · 2022 · Cellular and Molecular Bioengineering
  22. BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer
    Xu Zhu, Li Sun, Jingqin Lan, Linli Xu, Meng Zhang, Xuelai Luo, Jianping Gong, Guihua Wang, Xianglin Yuan, Junbo Hu et al. · 2016 · Oncotarget
  23. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer
    Victor Oginga Oria, Janine Terra Erler · 2023 · Cells
  24. Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS/miR-214-3p/CCL5 pathway
    Zhao Yang, Jiaqi Chen, Tianjie Liu, Yule Chen, Zhenkun Ma, Yizeng Fan, Zixi Wang, Shan Xu, Ke Wang, Xinyang Wang et al. · 2023 · Asian Journal of Andrology
  25. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers
    Yurina Maeshima, Tatsuki R. Kataoka, Alexis Vandenbon, Masahiro Hirata, Yasuhide Takeuchi, Yutaka Suzuki, Yukiko Fukui, Masahiro Kawashima, Masahiro Takada, Yumiko Ibi et al. · 2024 · EBioMedicine
  26. Lymphatics in Tumor Progression and Immunomodulation
    Claire Y. Li, Stav Brown, Babak Joseph Mehrara, Raghu P. Kataru · 2022 · International Journal of Molecular Sciences
  27. Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
    Zaoqu Liu, Ying Kong, Qin Dang, Siyuan Weng, Youyang Zheng, Yuqing Ren, Jinxiang Lv, Na Li, Yilin Han, Xinwei Han · 2022 · Frontiers in Immunology
  28. The cellular and molecular mediators of metastasis to the lung
    Oliver Cucanic, Rae H. Farnsworth, Steven A. Stacker · 2022 · Growth Factors
  29. Two Sides to the Same Coin—Cytotoxicity vs. Potential Metastatic Activity of AgNPs Relative to Triple-Negative Human Breast Cancer MDA-MB-436 Cells
    Magdalena Matysiak‐Kucharek, Magdalena Czajka, Barbara Jodłowska‐Jędrych, Krzysztof Sawicki, Paulina Wojtyła-Buciora, Marcin K. Kruszewski, Lucyna Kapka‐Skrzypczak · 2020 · Molecules
  30. Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy
    Alexandra R. Harris, Savieay Esparza, Mohammad Sadegh Azimi, Robert Cornelison, Francesca N. Azar, Danielle C. Llaneza, Maura C. Belanger, Alexander S. Mathew, Svyatoslav Tkachenko, Matthew J. Perez et al. · 2022 · Frontiers in Oncology
  31. Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation
    Cynthia Clemente-González, Amancio Carnero · 2022 · Cancers
  32. Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region
    Subash Chirkut · 2019 · Oncology Reviews
  33. The pro-tumorigenic responses in metastatic niches: an immunological perspective
    Mohammad Hossein Mirzapour, Mahsa Heidari‐Foroozan, Sepideh Razi, Nima Rezaei · 2022 · Clinical & Translational Oncology
  34. The pre-metastatic niche: mechanisms, heterogeneity, and therapeutic opportunities
    Xu-Ran Zhang, Bing Wei, Bing-Hua Jiang, Weihong Ren · 2026 · Molecular Cancer
  35. Lymphatic endothelial cells actively regulate prostate cancer cell invasion
    Tariq Kazim Shah, Flonné B. Wildes, Samata M. Kakkad, Dmitri Artemov, Zaver M. Bhujwalla · 2016 · NMR in Biomedicine
  36. Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics
    Liang-Hui Chu, Brian Herb Annex, Aleksander S. Popel · 2015 · Frontiers in Pharmacology
  37. Comparing the frequency of CD33+ pSTAT3+ myeloid‐derived suppressor cells and IL‐17+ lymphocytes in patients with prostate cancer and benign prostatic hyperplasia
    Mohammad‐Javad Sanaei, Fatemeh Taheri, Masoud Heshmati, Davood Bashash, Roya Nazmabadi, Mohammad-Alibeigi Faramarz, Mahboobeh Nahid‐Samiei, Hedayatollah Shirzad, Nader Bagheri · 2021 · Cell Biology International
  38. Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis
    Minjing Zou, Amal T. Qattan, Monther M Al-Alwan, Hazem Ghebeh, Naif Binjumah, Latifa Al‐Haj, Khalid S.A. Khabar, Abdulmohsen Altaweel, Falah Almohanna, Abdullah M. Assiri et al. · 2025 · Frontiers in Endocrinology
  39. Benign non-immune cells in tumor microenvironment
    Shaowen Liu, Chunhui Liu, Yuan He, Jun Li · 2025 · Frontiers in Immunology
  40. Clinical and molecular characterizations of HNSCC patients with occult lymph node metastasis
    Yicun Li, Yun Wu, Xiaolian Li, Yuntao Lin, Yuling Chen, Hongyu Yang, Yuehong Shen · 2025 · Scientific Reports
  41. Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets
    Chaochu Cui, Yongxi Zhang, Gang Liu, Shuhong Zhang, Jinghang Zhang, Xianwei Wang · 2021 · Exploration of Targeted Anti-tumor Therapy
  42. Cancer as a tool for preclinical psychoneuroimmunology
    Jeremy C. Borniger · 2021 · Brain Behavior & Immunity - Health
  43. Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer
    Kyungmin Ji, Zhiguo Zhao, Mansoureh Sameni, Kamiar Moin, Yong Xu, Robert J. Gillies, Bonnie F. Sloane, Raymond R. Mattingly · 2021 · Cancers
  44. Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth
    Giovanna Azzarito, Michele Visentin, Brigitte Leeners, Raghvendra Krishna Dubey · 2022 · International Journal of Molecular Sciences
  45. Emerging role of cancer-associated fibroblasts in the premetastatic niche
    Shuaixi Yang, Ying Guo, Jiachi Jia, Wenming Cui, Xinhao Zhang, Yuhang Wang, Zhiyuan Xie, Yingshuai Fang, Xianfei Ding, Lei Chang et al. · 2025 · Molecular Cancer
  46. Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis
    Jie Ma, Xue-Qin Chen, Zuo‐Lin Xiang · 2022 · Oxidative Medicine and Cellular Longevity
  47. Role of CD44-Positive Extracellular Vesicles Derived from Highly Metastatic Mouse Mammary Carcinoma Cells in Pre-Metastatic Niche Formation
    Ayana Ikari, Yuko Ito, Kohei Taniguchi, Masa-Aki Shibata, Kosei Kimura, Mitsuhiko Iwamoto, Sang‐Woong Lee · 2024 · International Journal of Molecular Sciences
  48. The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway
    Rina Takamiya, Motoko Takahashi, Yasuaki Uehara, Shigeru Ariki, Jiro Hashimoto, Yoshihiro Hasegawa, Yoshio Kuroki · 2014 · Biochemical and Biophysical Research Communications
  49. Associations amongst genes, molecules, cells, and organs in breast cancer metastasis
    S. Nathanson, L. C. Dieterich, Xiang-H.-F. Zhang, D. Chitale, L. Pusztai, Emma Reynaud, Yi-Hsuan Wu, A. Ríos-Hoyo · 2023 · Clinical and Experimental Metastasis
  50. Pro-adhesive phenotype of normal endothelial cells responding to metastatic breast cancer cell conditioned medium is linked to NFκB-mediated transcriptomic regulation
    Janini Mejía-Rangel, Emilio J. Córdova, Lorena Orozco, José Luis Ventura-Gallegos, Irma Beatriz Mitre-Aguilar, Alma R. Escalona-Guzman, Felipe Vadillo‐Ortega, José Vázquez‐Prado, Patricio Gariglio, Alejandro Zentella‐Dehesa · 2016 · International Journal of Oncology
  51. Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications
    Brusi Kola, Sooraj Kakkat, Prabhat Suman, Emily Crouch, Debanjan Chakroborty, Chandrani Sarkar · 2025 · The FASEB Journal
  52. Lymphatic Tissue and Organ Engineering for In Vitro Modeling and In Vivo Regeneration
    Anna M. Kolarzyk, Gigi Wong, Esak Lee · 2022 · Cold Spring Harbor Perspectives in Medicine
  53. Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application
    Chenghao Cao, Di Lu, Huigang Li, Pan Shen, Jianyong Zhuo, Zuyuan Lin, Chiyu He, Peiru Zhang, Songmin Ying, Xuyong Wei et al. · 2025 · MedComm
  54. Targeting STAT3 pathway: A promising immunotherapeutic strategy for triple-negative breast cancer – Current status and future outlooks
    Zahra Malekinejad, Elnaz Mehdizadeh Aghdam, Alireza Khodaei Ardakan, Emadaldin Forghan, Mahsan Alizadeh, Roxana Simiyari, Hamid Reza Heidari, Soheila Montazersaheb · 2025 · European Journal of Pharmacology
  55. CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2–CCL2, CCR5–CCL5, CCR4–CCL17/22, CCR6–CCL20, CCR7–CCL19/21
    Ingyu Bahng · 2026 · Frontiers in Immunology
  56. The covert symphony: cellular and molecular accomplices in breast cancer metastasis
    Hongjiang Si, Madelyn Esquivel, Erika Mendoza Mendoza, Kevin P. Roarty · 2023 · Frontiers in Cell and Developmental Biology
  57. Transient Lymphatic Remodeling Follows Sub-Ablative High-Frequency Irreversible Electroporation Therapy in a 4T1 Murine Model
    Savieay Esparza, Edward J. Jacobs, Jennifer H. Hammel, Sharon K. Michelhaugh, Nastaran Alinezhadbalalami, Margaret A. Nagai-Singer, Khan Mohammad Imran, Rafael V. Davalos, Irving C. Allen, Scott S. Verbridge et al. · 2025 · Annals of Biomedical Engineering
  58. The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast
    Sneha Pandithar, Daniel Galke, Ahone Akume, Artem Belyakov, Dominick Lomonaco, Amirah A. Guerra, Jay Park, Olivia Reff, Kideok Jin · 2024 · Molecular Biology Reports
  59. The Feasibility of Tumor-Related Angiogenesis Study as a Prognostic Factor for Cancer Development
    Игорь Валентинович Майбородин, S.E. Krasilnikov, Anton E. Koziakov, Бабаянц Екатерина Владимировна, А. П. Кулиджанян · 2015 · Novosti hirurgii
  60. Advances in the roles and molecular mechanisms of exosomal circular RNAs in regulating the pre-metastatic niche of tumors
    Wei Xu, Luyu Zhu, Shiqi Zhang, Xiaoyan Wang, Dandan Gong, Yu Fan · 2025 · Discover Oncology
  61. Targeting the chromatin structural changes of antitumor immunity
    Nian-nian Li, Dengxing Lun, Ningning Gong, Gang Meng, Xinying Du, He Wang, Xiangxiang Bao, Xinyang Li, Ji-wu Song, HU Ke-wei et al. · 2023 · Journal of Pharmaceutical Analysis
  62. Hypoxia
    Corbin C. Jensen, Noel A. Warfel · 2021 · Elsevier eBooks
  63. Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome
    Giovanna Azzarito, Margit Henry, Tamara Rotshteyn, Brigitte Leeners, Raghvendra Krishna Dubey · 2023 · Cells
  64. The Tight Relationship Between the Tumoral Microenvironment and Radium-223
    Miriam Conte, Miriam Tomaciello, Maria Silvia De Feo, Viviana Frantellizzi, Francesco Marampon, Flaminia De Cristofaro, Giuseppe De Vincentis, Luca Filippi · 2025 · Biomedicines
  65. A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
    Marvin Xuejun Xu, Xinxin Liu, Hai‐Liang Zhang, Hongyun Xu, Xiangyu Ma, Yupo Yang, Chaoqun Duan, Shanshun Tang, Yaqing Liu, Cen Li et al. · 2025 · British Journal of Pharmacology
  66. Catulin reporter marks a heterogeneous population of invasive breast cancer cells with some demonstrating plasticity and participating in vascular mimicry
    Mateusz Gielata, Kamila Karpińska, Aleksandra Gwiazdowska, Łukasz M. Boryń, Agnieszka Kobielak · 2022 · Scientific Reports
  67. Overexpression of VEGFA mediated by HIF‐1 is associated with higher rate of spread through air spaces in resected lung adenocarcinomas
    Liang Guo, Shaoling Li, Xing Wang, Yuming Zhu, Juanjuan Li · 2023 · The Journal of Gene Medicine
  68. Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients
    Alex Ganetsky, Todd A. Miano, Mitchell E. Hughes, Robert H. Vonderheide, David Porter, Ran Reshef · 2015 · Journal of Antimicrobial Chemotherapy
  69. Tagging the pre-metastatic node in oral cancer: A cross-sectional study
    Bhanu Priya, Anita E Spadigam, Anita Dhupar, Shaheen Syed · 2023 · Journal of Cancer Research and Therapeutics
  70. TGF-α/EGFR-mediated lymphatic metastasis reveals a repositionable therapeutic target in breast cancer
    Wenyang Shi, Yueyun Pan, Bhavik Rathod, Yuhan Wang, Zhi Wang, Jianyu Shen, Francesca Gatto, Mingzhi Liu, Yizhe Sun, Margareta Wilhelm et al. · 2026 · npj Breast Cancer
  71. Spatial organization of the TNBC tumor microenvironment: multicellular niches, T-cell bottlenecks, and therapeutic opportunities
    Jinpeng Wu, Jingjing Fan, Tong Sha, Hongtao Li · 2026 · Journal of Translational Medicine
  72. Cold atmospheric plasma jet applied for TiO2/carbon fiber composite biomaterial
    Limin Li, Zhiwei Li, Qinqin Zhou, Xiuxiang Huang, Ke Peng · 2020 · Laser and Particle Beams
  73. Tumor microenvironment and future targets of immunotherapy in breast cancer
    Qi Wang, Qiang Liu · 2020 · Translational Breast Cancer Research
  74. CCL5/CCR5 Axis in Cancer
    Manzoor Ahmad Mir, Aamina Manzoor, Nusrat Jan · 2023 · Springer eBooks
  75. Modulation of Chemokine Activity for Enhanced Angiogenesis and Tissue Regeneration in Chronic Wounds
    G Nideesh Adit, Srikanth Kavyashree, Kannan Harithpriya, Kumar Ganesan, Kunka Mohanram Ramkumar · 2026 · International Journal of Molecular Sciences
  76. From repair to disease: lymphatic contributions to regeneration, cancer and ageing
    Yuheng Zhang, Qi Tian, Yang Yang, Hanyu Liu, Taha Kadir Yesin, Wei Lu, Jessy D Joseph, Biswajyoti Borah, Saravana Kumar Ramasamy, Maximina Hee Yun et al. · 2026 · Journal of Advanced Research
  77. The chemokine network in triple-negative breast cancer: its role in immune microenvironment regulation, and prospects for targeted therapy
    Wanyu Wang, Linhua Chen, Wei Guo, Min Hu, Xuemei Han, Xuan Xia, Wanbin Xu, Wanjun Ma · 2026 · Frontiers in Immunology
  78. Premetastatic Microenvironment
    Yoshiro Maru · 2016 · Springer eBooks
  79. Lymphatic endothelial-like cells in the glioblastoma tumor niche drive metabolic alterations that promote stem cell proliferation and survival
    Reilly L. Kidwell, Manish Kumar Aghi · 2024 · Neuro-Oncology
  80. Identification of an immune classifier for predicting the prognosis and therapeutic response in triple-negative breast cancer
    Kuailu Lin, QIANYU GU, Xixi Lai · 2023 · Biocell
  81. Tratamento de câncer de mama utilizando terapia fotodinâmica com nonoemulsões de Ftalocianina de cloro alumínio
    Ludmilla David de Moura · 2017
  82. Mapping the intracellular molecular mechanisms of chemokine signalling within cancer
    Gerald Keil · 2019 · UEA Digital Repository (University of East Anglia)
  83. 25pSD-10 ASTRO-E衛星搭載硬X線検出器(HXD)の地上キャリブレーション
    直樹 磯部, T. Kamae, 一夫 牧島, 敏夫 村上, 忠幸 高橋, 信 田代, Y. Fukazawa, 昌彦 杉保, Y. Uchiyama, 縁 松本 et al. · 1999 · 日本物理学会講演概要集
  84. Premetastatic Microenvironment
    Yoshiro Maru · 2021 · Springer eBooks
  85. Establishment of Premetatatic Niche Formation and Clincal Application
    Kabulo Katshi Cedric · 2020 · Archives of Orthopedics and Rheumatology
  86. The Challenge of Liver Metastases: Evolving Knowledge and Treatment
    Anna Rossetto, Vittorio Bresadola, Brunilda Tatani, Alessandro Rosignoli, A Zompicchi- Atti, Alessandro Uzzau · 2023 · Journal of Surgery
  87. Lenfadenopatiye Multidisipliner Yaklaşım
    Mustafa Cenk Yılmaz, Semih Tan, Emine Tural, Itır Ebru Zemheri, Pınar Engin Zerk, Zerrin Kutlu, Eren Altun, Emine Kizilay, Çağlayan Keklikkıran, Ömer TOPDAĞI et al. · 2022 · Akademisyen Kitabevi eBooks
  88. C–C Motif Chemokine Ligand 5 (CCL5) as a Predictive Marker for Non-sentinel Lymph Node Presence in Initial-Stage Breast Cancer with 1–2 Affected Sentinel Lymph Nodes
    Yongyun Zhu, Mingxiang Zhang, Xin Liu, Min Xie, Honggang Xiang, Zheng-zhi Zhu · 2024 · Molecular Biotechnology
  89. RGAST: A Relational Graph Attention Network for Multi-Scale Cell-Cell Communication Inference from Spatial Transcriptomics
    Yuqiao Gong, Zhangsheng Yu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  90. ROLE OF HYPOXIA INDUCIBLE FACTOR-1? IN LYMPH NODE METASTASIS OF BREAST CANCER
    Galuh Widowati · 2024 · Berkala Ilmiah Kedokteran Duta Wacana
  91. CCR5-related signalling may link peripheral immune activation to brain chemokine responses in breast cancer
    Delyse McCaffrey, Cynthia Shannon Weickert, Adam K. Walker · 2025 · Journal of Neuroimmunology
  92. Additional file 1 of Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung
    Zhengzheng Zhang, Zhiyan Yao, Zhang, Zimeng, Cui, Ling, Ling Zhang, Qiu, Gang, Song Xiaotian, Song, Shuxia · 2024 · Figshare
  93. Additional file 2 of Gastric cancer-derived LBP promotes liver metastasis by driving intrahepatic fibrotic pre-metastatic niche formation
    Xie, Li, Shengkui Qiu, Chen Lu, Gu, Chao, Jihuan Wang, Jialun Lv, Lang Fang, Chen, Zetian, Li, Ying, Tianlu Jiang et al. · 2024 · Figshare
  94. Additional file 2 of Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung
    Zhengzheng Zhang, Zhiyan Yao, Zhang, Zimeng, Cui, Ling, Zhang, Ling, Qiu, Gang, Song Xiaotian, Song, Shuxia · 2024 · Figshare
  95. Modulation of tumor-associated lymphangiogenesis by combination immunotherapy approaches in triple-negative breast cancer: a systematic review
    María Guerrero-Sánchez, Lisa Martens, Melissa García‐Caballero · 2026 · Frontiers in Immunology
  96. Empowering multifaceted analysis of spatial transcriptomics data with RGAST
    Yuqiao Gong, Xin Yuan, Zhangsheng Yu · 2026 · Briefings in Bioinformatics
  97. Cancer metastasis: biological mechanisms, therapeutic bottlenecks, and emerging interventions
    Huali Ye, Yuquan Wei, Xuemei He, Xiawei Wei · 2026 · Journal of Hematology & Oncology
  98. Immune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation
    Liuhai Zeng, Haiyan Wu, Shihang Xue, Minzhi Chen, Jian Song, Wei Lin · 2026 · Frontiers in Immunology
  99. Tumor-Educated Lymph Nodes: Comprehensive Remodeling or Stepwise
    Li-Ya Wei, Zi-Zhan Li, Lei‐Ming Cao, Kan Zhou, Guang-Rui Wang, Han-Yue Luo, Bing Liu, Xiao-Long Wang, Lin‐Lin Bu · 2026 · Critical Reviews in Oncology/Hematology